![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LumiThera’s Dry AMD Treatment Device Gains CE Mark
LumiThera’s Dry AMD Treatment Device Gains CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images6/LumiThera_Logo.gif?t=1529713370&width=430)
June 22, 2018
LumiThera’s LT-300 device, used for treating dry advanced macular degeneration, has earned a CE Mark.
The device uses the company’s LT-300 light delivery system to treat patients who suffer from a loss of central vision.
The treatment incorporates low level light therapy, applying red and near-infrared light to improve and repair tissue that has experienced degeneration or injury.
Upcoming Events
-
21Oct